Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-24 @ 11:44 PM
NCT ID:
NCT04783051
Eligibility Criteria:
Inclusion Criteria:
1. Gestation ≥16 weeks;
2. Age: ≥18 years;
3. Residence within the health facility catchment area;
4. Willing to adhere to study requirements and to deliver at the health facility.
5. Willing to provide written informed consent; if the woman is illiterate, she can choose an impartial witness, not related to the study, to accompany her during the informant consent process and they will both sign the informed consent form
Exclusion Criteria:
1. Known history of allergy to SP or to an ACT
2. An ongoing antibioprophylaxis with cotrimoxazole,
3. Current issue requiring hospital admission (including severe malaria as defined by WHO)
4. Pregnancy at high risk
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04783051
Study Brief:
Protocol Section:
NCT04783051